No. 20-3, September 2021
Index
- In the absence of global antitrust law: looking to “bricks and mortar” institutions and agency networks
- Vaccine nationalism and equitable access to COVID-19 pharmaceuticals: TRIPS Agreement under trial (again)
- In the absence of global antitrust law: looking to “bricks and mortar” institutions and agency networks
- Vaccine nationalism and equitable access to COVID-19 pharmaceuticals: TRIPS Agreement under trial (again)